ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1141

Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM

Rong Mu1, Hongbin Li2, Zhanyun Da3, Anbin Huang4, Hongzhi Wang5, Jing Lu6, Jianhong Wu7, Shengtao Zhang8, Yikai Yu9, Chun Li10, Shouxin Li9, Peng Ji11, Hua Wei12, Bin Wu13, Zhenbin Li14, Lingxun Shen15, Yanping Zhao16, Yi Zhao17, Xiaoqiang Hou18, Hui Xiao19, Yuhua Jia20, Bing Wu20, Yonggang Zhao20, Xin Chen19, Miaomiao Song20, Fei Xiao20 and Zhanguo Li21, 1People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), 2The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China (People's Republic), 3The affiliated Hospital of Nantong University, Nantong, Jiangsu, China (People's Republic), 4Union Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, WuHan, China (People's Republic), 5The First Hospital of Jiaxing, Jiaxing, China (People's Republic), 6First Affiliated Hospital of China Medical University, Shenyang, China (People's Republic), 7Department of Rheumatology, Dazhou Central Hospital, Dazhou, China (People's Republic), 8Tongji Hospital Affiliated Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China (People's Republic), 9Tongji Hospital Affiliated to Tongji Medical College of HUST, Wuhan, Hubei, China (People's Republic), 10People's Hospital, Beijing University Medical School, beijing, China (People's Republic), 11The first affiliated hospital of xinjiang medical university, Urumqi, Xinjiang, China (People's Republic), 12Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 13Chongqing Hospital of Traditional Chinese Medicine, chongqing, China (People's Republic), 14Chinese people ’s liberation army joint service support force 980 hospital, shijiazhuang, Jiangxi, China (People's Republic), 15Union Hospital Affiliated Tongji Medical College of HUST, Wuhan, Hubei, China (People's Republic), 16First Affiliated Hospital of Harbin Medical University, Harbin, China (People's Republic), 17Xuanwu Hospital, Capital Medical University, Beijing, China, Beijing, China (People's Republic), 18Yichang Central People's Hospital, Beijing, China (People's Republic), 19Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 20Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic), 21Peking University People’s Hospital, Xicheng, Beijing, China (People's Republic)

Meeting: ACR Convergence 2020

Keywords: COVID-19, Disease Activity, Health Services Research, Patient reported outcomes, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Treat-to-target (T2T), achieving a DAS28 below 3.2 is the main management strategy for RA. The Chinese New Year is a long holiday started in Jan. or Feb. based on the lunar calendar. Few clinics were available and most of the patients could returned to their hometown for over a month. The Chinese New Year of 2020 initiated at the end of January, which was overlapped with the quarantine of the COVID-19 epidemic. The whole country was locked down till late of April.

The purpose of this study was to evaluate T2T status of RA patients under double hits by long holiday and COVID-19 lockdown via the Smart System of Disease Management (SSDM).

Methods: SSDM is an interactive mobile disease management tool, including two application systems (APPs) for both doctors and patients. From Jun. 2014 to Jun. 2020, more than 180,000 patients with rheumatic diseases were trained to use SSDM. After executing DAS28 assessment, inputting treatment regiments and lab test records by patients themselves, all data can be synchronized automatically to the authorized physicians’ tool. The doctors can practice online consultation and continue or adjust treatment regiments based on patients’ profile.

Data were extracted from SSDM cloud to develop data analysis model by python software based on data mining since January 2015 to June 10, 2020, and monthly distribution models of the T2T rate were structured. Changes in SSDM online services such as consultation and refilling/adjusting medicines before and during the outbreak were evaluated. Calculations of the monthly average T2T from 2015 to 2019 in spring season, and comparations with the rate of the T2T rate in 2020 were performed.

Results: From June 2014 to June 2019, 56,546 adult RA patients (mean age was 51.35±14.13 years, and median disease duration was 45.97 months) performed self-assessment of DAS28 totally for 127,316 times via SSDM. The T2T rates were the lowest in the year during consecutive 3 months after Chinese New Year eve throughout 2015-2019. In 2020, the country was locked down on January 23, the New Year Eve. Compared with 2019, the T2T rates of RA patients increased significantly by 11.3%, 15.8%, 12.0% and 10.4% from January to April 2020, and was also significantly higher than monthly average rate in same period of 2016-2019. (p<0.01) Fig 1.

During the COVID-19 epidemic, the interactions between doctors and patients via SSDM was increased significantly. SSDM data in holiday-epidemic season showed 628 rheumatologists from 277 hospitals provided 9,924 consultations for 6,041 RA patients. And 407 rheumatologists in 192 hospitals conducted 3,493 refilling/adjusting medications for 2,233 patients. Compared with 2019, the number of consultations has increased by 2.85 times, and the number of medication refill/adjustment had increased by 4.29 times.

Conclusion: The T2T rate of RA patients was lowest in every past Chinese New Year season. During the COVID-19 epidemic, the trend of decline at T2T rates were reversed by strengthen SSDM’s online consultation and continued medication services. Through active interactions between rheumatologists and patients via SSDM, the outcomes were improved and the double hits of Chinese New Year-Epidemic turned out to be a happy accident for Chinese RA patients.


Disclosure: R. Mu, None; H. Li, None; Z. Da, None; A. Huang, None; H. Wang, None; J. Lu, None; J. Wu, None; S. Zhang, None; Y. Yu, None; C. Li, None; S. Li, None; P. Ji, None; H. Wei, None; B. Wu, None; Z. Li, None; L. Shen, None; Y. Zhao, None; Y. Zhao, None; X. Hou, None; H. Xiao, None; Y. Jia, None; B. Wu, None; Y. Zhao, None; X. Chen, None; M. Song, None; F. Xiao, None; Z. Li, None.

To cite this abstract in AMA style:

Mu R, Li H, Da Z, Huang A, Wang H, Lu J, Wu J, Zhang S, Yu Y, Li C, Li S, Ji P, Wei H, Wu B, Li Z, Shen L, Zhao Y, Zhao Y, Hou X, Xiao H, Jia Y, Wu B, Zhao Y, Chen X, Song M, Xiao F, Li Z. Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/reversing-seasonal-decline-of-t2t-outcome-in-ra-patients-under-double-hits-by-chinese-new-year-and-covid-19-epidemic-via-online-interaction-with-ssdm/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reversing-seasonal-decline-of-t2t-outcome-in-ra-patients-under-double-hits-by-chinese-new-year-and-covid-19-epidemic-via-online-interaction-with-ssdm/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology